Phase 1a Study Of The Safety, Tolerability And Pharmacokinetics Of Abi-H2158, A Novel Second-Generation Hbv Core Inhibitor, In Healthy Volunteers
JOURNAL OF HEPATOLOGY(2019)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要
JOURNAL OF HEPATOLOGY(2019)